Article
- The EMBO Journal (2005) 24, 2543 - 2555
- doi:10.1038/sj.emboj.7600729
Published online: 30 June 2005
Subject Category:
Repression of Runx2 function by TGF-
through recruitment of class II histone deacetylases by Smad3
Jong Seok Kang1, Tamara Alliston1, Rachel Delston1 and Rik Derynck1
- Department of Cell and Tissue Biology, Department of Anatomy, Programs in Cell Biology and Developmental Biology, University of California, San Francisco, CA, USA
Correspondence to:
Rik Derynck, Department of Cell and Tissue Biology, Programs in Cell Biology and Developmental Biology, University of California, San Francisco, CA 94143-0512, USA. Tel.: +1 415 476 7322; Fax: +1 415 476 1499; E-mail: derynck@itsa.ucsf.edu
Received 11 January 2005; Accepted 3 June 2005
Abstract
Transforming growth factor-
(TGF-
) inhibits osteoblast differentiation through inhibition of the function of Runx2 (Cbfa1) by Smad3. The mechanism through which TGF-
/Smad3 inhibits Runx2 function has not been characterized. We show that TGF-
induces histone deacetylation, primarily of histone H4, at the osteocalcin promoter, which is repressed by TGF-
, and that histone deacetylation is required for repression of Runx2 by TGF-
. This repression occurs through the action of the class IIa histone deacetylases (HDAC)4 and 5, which are recruited through interaction with Smad3 to the Smad3/Runx2 complex at the Runx2-binding DNA sequence. Accordingly, HDAC4 or 5 is required for efficient TGF-
-mediated inhibition of Runx2 function and is involved in osteoblast differentiation. Our results indicate that class IIa HDACs act as corepressors for TGF-
/Smad3-mediated transcriptional repression of Runx2 function in differentiating osteoblasts and are cell-intrinsic regulators of osteoblast differentiation.
Keywords:
- CBFA1,
- chromatin remodeling,
- mesenchymal differentiation,
- osteoblast,
- transcription
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Nature Review (09 Oct 2003)
TGF-β signaling in tumor suppression and cancer progression
Nature Genetics Progress (01 Oct 2001)
RESEARCH
Essential role of Id2 in negative regulation of IgE class switching
Nature Immunology Article (01 Jan 2003)
The EMBO Journal Article (01 May 2001)
The type I TGF-β receptor is covalently modified and regulated by sumoylation
Nature Cell Biology Article (01 Jun 2008)



